[1] Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol, 2007; 6, 182-7. doi:  10.1016/S1474-4422(07)70031-5
[2] Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation, 2015; 131, e29-e322.
[3] Goldstein LB, Adams R, Becker K, et al. Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation, 2001; 32, 280-99. http://www.ncbi.nlm.nih.gov/pubmed/11136952
[4] Ridker P, Kastelein J, Genest J, et al. C-reactive protein and cholesterol are equally strong predictors of cardiovascular risk and both are important for quality clinical care. Eur Heart J, 2013; 34, 1258-61. doi:  10.1093/eurheartj/eht022
[5] Osawa H, DoiY, Makino H, et al. Diabetes and hypertension markedly increased the risk of ischemic stroke associated with high serum resistin concentration in a general Japanese population: the Hisayama Study. Cardiovasc Diabetol, 2009; 8, 60. doi:  10.1186/1475-2840-8-60
[6] Youn C, Choi S, Kim S, et al. Serum highly selective C-reactive protein concentration is associated with the volume of ischemic tissue in acute ischemic stroke. Am J Emerg Med, 2012; 30, 124-8. doi:  10.1016/j.ajem.2010.11.006
[7] Pierdomenico S, Pierdomenico A, Cuccurullo F. Morning blood pressure surge, dipping, and risk of ischemic stroke in elderly patients treated for hypertension. Am J Hypertens, 2014; 27, 564-70. doi:  10.1093/ajh/hpt170
[8] Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men. N Engl J Med, 1997; 336, 973-9. doi:  10.1056/NEJM199704033361401
[9] Rost N, Wolf P, Kase C, et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke, 2001; 32, 2575-9. doi:  10.1161/hs1101.098151
[10] Ridker P, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med, 2002; 347, 1557-65. doi:  10.1056/NEJMoa021993
[11] Ridker PM, Hennekens CH, Buring JE, et al. C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women. N Engl J Med, 2000; 342, 836-43. doi:  10.1056/NEJM200003233421202
[12] Genest J, McPherson R, Frohlich J, et al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations. Can J Cardiol, 2009; 25, 567-79. doi:  10.1016/S0828-282X(09)70715-9
[13] Greenland P, Alpert JS, Beller GA, et al. 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol, 2010; 56, e50-e103. doi:  10.1016/j.jacc.2010.09.001
[14] Visser M, Bouter LM, McQuillan GM, et al. Elevated c-reactive protein levels in overweight and obese adults. JAMA, 1999; 282, 2131-5. doi:  10.1001/jama.282.22.2131
[15] Nevill AM, Stewart AD, Olds T, et al. Relationship between adiposity and body size reveals limitations of BMI. Am J Phys Anthropol, 2006; 129, 151-6. doi:  10.1002/(ISSN)1096-8644
[16] Dhana K, Kavousi M, Ikram MA, et al. Body shape index in comparison with other anthropometric measures in prediction of total and cause-specific mortality. J Epidemiol Community Health, 2016; 70, 90-6. doi:  10.1136/jech-2014-205257
[17] Krakauer NY, Krakauer JC. A New Body Shape Index Predicts Mortality Hazard Independently of Body Mass Index. PLoS One, 2012; 7, e39504. doi:  10.1371/journal.pone.0039504
[18] Heymsfield SB, Scherzer R, Pietrobelli A, et al. Body Mass Index as a Phenotypic Expression of Adiposity: Quantitative Contribution of Muscularity in a Population-Based Sample. Int J Obes (Lond), 2009; 33, 1363-73. doi:  10.1038/ijo.2009.184
[19] Li H, Xu T, Tong W, et al. Comparison of Cardiovascular Risk Factors Between Prehypertension and Hypertension in a Mongolian Population, Inner Mongolia, China. Circ J, 2008; 72, 1666-73. doi:  10.1253/circj.CJ-08-0138
[20] Perloff D, Grim C, Flack J, et al. Human blood pressure determination by sphygmomanometry. Circulation, 1993; 88, 2460-70. doi:  10.1161/01.CIR.88.5.2460
[21] Xu T, Bu X, Li H, et al. Smoking, Heart Rate, and Ischemic Stroke: A Population-Based Prospective Cohort Study Among Inner Mongolians in China. Stroke, 2013; 44, 2457-61. doi:  10.1161/STROKEAHA.111.000648
[22] Stroke--1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders. Stroke, 1989; 20, 1407-31.
[23] DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics, 1988; 44, 837-45. doi:  10.2307/2531595
[24] The Global Burden of Metabolic Risk Factors for Chronic Diseases C. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants. Lancet, 2014; 383, 970-83. doi:  10.1016/S0140-6736(13)61836-X
[25] Fox CS, Massaro JM, Hoffmann U, et al. Abdominal Visceral and Subcutaneous Adipose Tissue Compartments. Circulation, 2007; 116, 39-48. doi:  10.1161/CIRCULATIONAHA.106.675355
[26] Krakauer NY, Krakauer JC. Dynamic Association of Mortality Hazard with Body Shape. PLoS One, 2014; 9, e88793. doi:  10.1371/journal.pone.0088793
[27] Grant JF, Chittleborough CR, Shi Z, et al. The association between A Body Shape Index and mortality: Results from an Australian cohort. PLoS One, 2017; 12, e0181244. doi:  10.1371/journal.pone.0181244
[28] Sato Y, Fujimoto S, Konta T, et al. Body shape index: Sex-specific differences in predictive power for all-cause mortality in the Japanese population. PLoS One, 2017; 12, e0177779. doi:  10.1371/journal.pone.0177779
[29] Thomson CA, Garcia DO, Wertheim BC, et al. Body Shape, Adiposity Index, and Mortality in Postmenopausal Women: Findings from the Women's Health Initiative. Obesity, 2016; 24, 1061-9. doi:  10.1002/oby.v24.5
[30] Bouchi R, Asakawa M, Ohara N, et al. Indirect measure of visceral adiposity 'A Body Shape Index' (ABSI) is associated with arterial stiffness in patients with type 2 diabetes. BMJ Open Diabetes Res Care, 2016; 4, e000188. doi:  10.1136/bmjdrc-2015-000188
[31] Ji M, Zhang S, An R. Effectiveness of A Body Shape Index (ABSI) in predicting chronic diseases and mortality: a systematic review and meta-analysis. Obes Rev, 2018; 19, 737-59. doi:  10.1111/obr.v19.5
[32] Zimmermann O, Li K, Zaczkiewicz M, et al. C-Reactive Protein in Human Atherogenesis: Facts and Fiction. Mediators Inflamm, 2014; 2014, 561428. http://pubmedcentralcanada.ca/pmcc/articles/PMC3995305/
[33] Pepys MB, Hirschfield GM. C-reactive protein: a critical update. [J]lin Invest, 2003; 111, 1805-12. doi:  10.1172/JCI200318921
[34] Zwaka TP, Hombach V, Torzewski J. C-Reactive Protein–Mediated Low Density Lipoprotein Uptake by Macrophages: implications for atherosclerosis. Circulation, 2001; 103, 1194-7. doi:  10.1161/01.CIR.103.9.1194
[35] Lagrand WK, Visser CA, Hermens WT, et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation, 1999; 100, 96-102. doi:  10.1161/01.CIR.100.1.96
[36] Libby P, Aikawa M. Effects of statins in reducing thrombotic risk and modulating plaque vulnerability. Clin Cardiol, 2003; 26, 11-4. doi:  10.1002/clc.v26:1+
[37] Sung KC, Ryu S, Chang Y, et al. C-reactive protein and risk of cardiovascular and all-cause mortality in 268 803 East Asians. Eur Heart J, 2014; 35, 1809-16. doi:  10.1093/eurheartj/ehu059
[38] Ridker PM, Buring JE, Shih J, et al. Prospective Study of C-Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Healthy Women. Circulation, 1998; 98, 731-3. doi:  10.1161/01.CIR.98.8.731
[39] Arenillas JF, Álvarez-Sabín J, Molina CA, et al. C-Reactive Protein Predicts Further Ischemic Events in First-Ever Transient Ischemic Attack or Stroke Patients With Intracranial Large-Artery Occlusive Disease. Stroke, 2003; 34, 2463-8. doi:  10.1161/01.STR.0000089920.93927.A7
[40] Thompson AM, Zhang Y, Tong W, et al. Association of obesity and biomarkers of inflammation and endothelial dysfunction in adults in Inner Mongolia, China. Int J Cardiol, 2011; 150, 247-52. doi:  10.1016/j.ijcard.2010.04.011
[41] Yang CW, Li CI, Li TC, et al. Association of Sarcopenic Obesity with Higher Serum High-Sensitivity C-Reactive Protein Levels in Chinese Older Males - A Community-Based Study (Taichung Community Health Study-Elderly, TCHS-E). PLoS One, 2015; 10, e0132908. doi:  10.1371/journal.pone.0132908
[42] Sanip Z, Ariffin FD, Al-Tahami BAM, et al. Obesity indices and metabolic markers are related to hs-CRP and adiponectin levels in overweight and obese females. Obes Res Clin Pract, 2013; 7, e315-20. doi:  10.1016/j.orcp.2012.05.002
[43] Carmena R, Ascaso JF, Real JT. Impact of obesity in primary hyperlipidemias. Nutr Metab Cardiovasc Dis, 2001; 11, 354-9. http://www.ncbi.nlm.nih.gov/pubmed/11887432
[44] Faraj M, Messier L, Bastard JP, et al. Apolipoprotein B: a predictor of inflammatory status in postmenopausal overweight and obese women. Diabetologia, 2006; 49, 1637-46. doi:  10.1007/s00125-006-0259-7
[45] Firdous S. Correlation of CRP, fasting serum triglycerides and obesity as cardiovascular risk factors. J Coll Physicians Surg Pak, 2014; 24, 308-13. http://europepmc.org/abstract/med/24848386
[46] Ridker PM, Rifai N, Clearfield M, et al. Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events. N Engl J Med, 2001; 344, 1959-65. doi:  10.1056/NEJM200106283442601
[47] Horvei LD, Grimnes G, Hindberg K, et al. C-reactive protein, obesity, and the risk of arterial and venous thrombosis. J Thromb Haemost, 2016; 14, 1561-71. doi:  10.1111/jth.13369